Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: The second national registry of myocardial infarction

American Heart Journal

Volumn 141, Issue 1, 2001, Pages 65-72

  Goldberg, Robert J ^a,b   Gore, Joel M ^a   Thompson, Craig A ^c   Gurwitz, Jerry H ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Lown Cardiovascular Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; DYING; FEMALE; HIGH RISK PATIENT; HOSPITAL; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGISTER; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; UNITED STATES;

EID: 0035161304     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.111405     Document Type: Article

References (31)

1. Cardiogenic shock
2. Cardiogenic shock: Current understandings and future research directions
3. Cardiogenic shock complicating myocardial infarction
4. Shock after acute myocardial infarction: A clinical and hemodynacute myocardial infarction profile
5. Risk identification at the time of admission to coronary care unit in patients with suspected myoardial infarction
6. The treatment of cardiogenic shock, I: The nature of cardiogenic shock
7. Effect of medical treatment of acute myocardial infarction in coronary care unit-study on its effect mainly on the cases with complication
8. Time trends in prognosis of patients with myocardial infarction: A population-based study
9. The in-hospital development of cardiogenic shock after infarction: Incidence, predictors of occurrence, outcome and prognostic factors: The MILIS study group
10. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome
11. Cardiogenic shock after myocardial infarction: Incidence and mortality from a community-wide perspective, 1975 to 1988
12. Temporal trends in cardiogenic shock complicating acute myocardial infarction
13. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: Results of an international registry
14. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock
15. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock
16. Multicenter registry of angioplasty therapy of cardiogenic shock: Initial and long term survival
17. Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction
18. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction
19. Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience
20. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation
21. Intra-aortic balloon counterpulsation in cardiogenic shock: Report of a cooperative clinical trial
22. Intraaortic balloon counterpulsation with and without reperfusion for acute myocardial infarction shock
23. Cardiogenic shock complicating acute myocardial infarction: The use of coronary angioplasty and the integration of new support devices
24. Emergency cardiac procedures in patients in cardiogenic shock due to complications of coronary artery disease
25. Prognosis in cardiogenic shock after acute myocardial infarction in the intervention area
26. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
27. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction
28. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent
29. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy
30. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: Results from the GUSTO trial
31. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial: An observational study